Physician profile
Davida A Baxter
NPI 1962579599
$1,626.00
in general payments reported to CMS, 2019-2025
11 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.44 · 2020: $299 · 2021: $96.91 · 2022: $182 · 2023: $401 · 2024: $425 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $312.87 | 2019-2023 | Cequa |
| Coopervision INC. | $218.19 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $208.82 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $190.19 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $179.08 | 2019-2025 | Eysuvis, Total30, Precision 1 |
| Novartis Pharmaceuticals Corporation | $150.00 | 2019-2020 | |
| Dompe US, INC. | $116.86 | 2024 | Oxervate |
| Optos, INC. | $111.62 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $100.55 | 2024 | Acuvue |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davida Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.